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ABSTRACT: We report the application of a novel scaffold design in a sheep thoracic spine model for 
spine deformity correction. The combination of the calcium-phosphate coated polycaprolactone 
scaffolds with recombinant human bone morphogenic protein-2 are intended as a future bone graft 
substitute in ensuring the stability of bony intervertebral fusion. A solid free-form fabrication 
process based on melt extrusion has been utilized in the manufacturing of these scaffolds. 
 
 
1 INTRODUCTION 
 
1.1 Background 
Anterior spinal surgery is a well- recognized and effective approach for adolescent idiopathic 
scoliosis correction (Dubousset 2001a, b; Lowenstein et al. 2007). The success of anterior scoliosis 
surgery depends on achieving a solid bony fusion between adjacent vertebrae after the 
intervertebral discs have been surgically cleared and the disc spaces filled with graft material. The 
golden standard for bone grafting in spinal fusion surgery is autograft (host graft material), however 
limited availability and donor site morbidity make synthetic alternatives to autograft desirable. 
Current research focuses on the development of synthetic scaffolds in combination with growth 
factors such as recombinant human bone morphogenic protein-2 (rhBMP-2) to achieve solid bony 
fusion following scoliosis surgery (Sandhu 2000a, b; Sawyer 2009, c; Abbah et al. 2009). To date 
there are no studies examining the use of such biodegradable implants in a sheep thoracic spine 
model. 
1.2 Aim 
 
The aim of the current project is to design and fabricate biodegradable polycaprolactone (PCL) 
scaffolds by using a solid free-form fabrication process based on melt extrusion. These scaffolds are 
coated with a biomimetic calcium phosphate (CaP) layer which actively promotes bone ingrowth and 
regeneration. Following functionalization of these scaffolds with rhBMP-2, surgical implantation is 
undertaken at one of the predefined thoracic spinal levels of either T5/6, T7/8 or T9/10.  
 
2 MATERIALS AND METHODS 
 
2.1 Anatomical considerations 
 
Sheep (ovis aries) have been widely used in a large number of interbody spinal fusion models 
(Cunningham 1998a, b; Sandhu 2000, c; Sawyer 2009, d; Abbah et al. 2009). The physical size of the 
sheep spine is deemed sufficient to allow spinal surgery to be readily carried out and to allow for 
assessment of the success of the study using biomechanical testing, radiological and histological 
analysis. In addition, sheep are a large animal model which simulates an environment representative 
of an adolescent child, while securing optimal application and fixation techniques closely 
corresponding to that in the human spine (Easley 2008). Sheep have also been established for use in 
both open chest spinal surgery as well as minimally invasive endoscopic assisted surgery 
(Cunningham 1998). 
 
2.2 Scaffold design 
 
The scaffold design has been conceptualized through cadaveric dissections. Solid acrylonitrile 
butadiene styrene (ABS) prototypes of the scaffold were first designed and manufactured in 
different thicknesses by fused deposition modeling (Dimension SST 768), and after trial 
implantations of the spinal thoracic levels of T5/6, T7/8 and T9/10, the optimal scaffold geometry 
was confirmed and a thickness of 2.5 mm was decided to be most appropriate for this animal 
Polycaprolactone-based scaffold plus BMP-2 in a sheep thoracic spine fusion model. The final 
scaffold design was based on a 0°-90° lay-down pattern plus scaffold contour to confer additional 
strength for surgical handling and implantation of the prepared disc space. The scaffolds (Figure 1.) 
were fabricated using PCL and a Dual_BioExtruder, a computer-controlled extrusion- based additive 
manufacturing device developed in-house at the Polytechnic University of Leiria, Portugal (Domingos 
et al. 2010). The semicircular shape conforms to the cleared anterior intervertebral disc space 
ensuring a low-profiled construct under compression. 
 
2.3 Surgical procedure 
 
In this in vivo sheep study, three thoracic intervertebral spaces (T5/6, T7/8, T9/10) in each animal 
receive either (i) PCL + CaP scaffold + rhBMP-2 (ii) PCL + CaP scaffold alone, or (iii) rib head autograft. 
The treated intervertebral disc spaces are stabilized with a 5.5mm titanium rod secured with two 
vertebral screws. 
 
3 RESULTS 
 
3.1 Micro CT analysis  
 
The porosity of uncoated scaffolds measured 55.6±0.9% with an average pore size of 406±6 μm and 
average strut diameter of 328±6 μm. The calcium phosphate coating of the scaffolds conferred an 
increase in scaffold strut size (340±4 μm) which resulted in a decrease of pore size (386±5 μm) and 
porosity (49.9±2.0%). The μCT was also used to determine the cross-sectional surface area (103.3 
mm2) that was used for the compressive modulus and yield stress calculations. A representative 3D 
rendered image of a scanned scaffold is presented in Figure 1. 
 
 
 
 
Figure 1.  μCT 40 scan of a fabricated scaffold 
 
3.2 Compressive testing of scaffolds 
 
 
 
 
Figure 2. Representative force-strain diagram of compression test on uncoated scaffold. 
 
From the compression tests, no influence of the coating procedure on the mechanical properties 
could be observed. Figure 2. depicts a representative force-strain diagram, showing an initial 
alignment phase (up to 10 %) followed by elastic deformation with a stiffness value of 9.4±1.3 N/% 
or an elastic modulus of 9.1±1.25 MPa. The scaffolds yielded at 25±1% strain and 117±14 N 
(1.14±0.13 MPa), after which permanent deformation progressively increases as the load is 
increased. 
 
Macroscopic observation of compressed scaffolds revealed thinning of the construct by shearing 
between the deposited layers of material, while both the internal pore architecture and the overall 
scaffold shape and consistency were largely preserved. This observation is important as the 
preservation of the scaffold’s overall shape once implanted surgically within the sheep’s 
intervertebral disc space and placed under compression is a condition sine qua non. 
 
3.3 Scanning electron microscopy (SEM) 
 
Biomimetic properties of the calcium phosphate coating of the scaffolds actively promote bone 
regeneration. The coating of these scaffolds involve immersion in concentrated simulated body fluid 
(x10) and scaffold surface activation (Yang et al. 2008). Confirmation of the coating can be seen with 
SEM. Preliminary results show a heterogeneous coating whereby there is a clear difference between 
lightly coated outer layers of the scaffold contrasting with well-rounded coatings of central (inner) 
strut filaments. 
 
3.4 Fusion assessments 
 
To date, two pilot surgeries with implantation of earlier scaffold prototypes have been successfully 
undertaken. Triple bone fusion assessments (i.e. biomechanical testing, radiological imaging and 
histological analysis) of individual functional spinal units at the 6- month mark is currently underway. 
A functional spinal unit (FSU) consists of an instrumented intervertebral disc level as well as the 
adjoining top and bottom vertebrae. (See Figure 3.) 
 
 
 
 
 
 
Figure 3. PCL-based scaffold in situ within a predefined intervertebral disc space. Internal  
fixation with a 5.5mm titanium rod and two vertebral screws stabilize the functional  
spinal unit. The 5.5mm titanium rod has been removed for illustrative purposes. 
 
4 DISCUSSION 
 
Bony fusion is essential for long-term stability of instrumented spinal segments in the setting of 
scoliosis deformity correction. Increasingly being studied are biologically active substances intended 
to extend, enhance, or even replace autologous graft. The use of rhBMP-2 as an osteoinductive 
implant component has been on the increase because of its proven potency in vivo (Burkus 2004).  
 
The biomedical application of these PCL-based scaffolds aims at providing a structural support that 
promotes the repair and regeneration of tissues in combination of living cells and biologically active 
molecules. Bone formation is actively guided with the ensuing cell colonization, migration, growth 
and differentiation. This forms the basis of a viable tissue engineered construct (TEC) (Hutmacher 
2007). 
 
Scaffolds are required to provide sufficient initial mechanical strength and stiffness to substitute for 
the mechanical function of bone. This permits cell migration and population of the scaffold in vivo. In 
addition, the scaffold material should be adequately robust to resist deformation upon cell 
infiltration as well as wound contraction forces in vivo. An internal fixation construct stabilises the 
instrumented disc space thus reduces the mechanical role of the scaffold in situ. This maintains 
sufficient structural integrity critical to a stable biomechanical environment for vascularization and 
bone remodeling. This has been successfully demonstrated by Abbah et al. in an analogous porcine 
lumbar interbody fusion model whereby complete bony fusion was seen as early as 3 months with 
advanced bone remodeling at 6 months (Abbah et al. 2009). 
 
A scaffold pore size of 406 +/- 6 microns with 100% pore interconnectivity fulfills the required 
minimum of 300 micron pore size recommended for sufficient vascularization of tissue-engineered 
graft (Karageorgiou et al. 2005). The scaffold architecture consists of a honeycomb configuration 
which is a regular two-dimensional array of polygonal pores, each defined by a wall shared between 
adjacent pores (Gibson et al. 1997). Structurally this consists of a 90 degree lay-down pattern which 
offers a hexagonal pore architectural pattern conferring desirable physiological and mechanical 
properties by way of combining high stiffness and strength with open vertical pore channels that 
facilitate bone ingrowth. Yeo et al. in an in vivo application of scaffolds fabricated to similar 
dimensions matched closely the exhibited compressive strength and modulus of cancellous bone 
confirming its potential as a bone graft substitute (Yeo et al. 2008). 
 
Calcium phosphate coating of these PCL scaffolds is intended to enhance its bioactivity hence 
promoting bone formation. The external scaffold geometry has been customized to allow for a 
lowprofiled construct confirming to the anatomical landmarks of the spine. This aims at a greater 
integration and guided spinal fusion. (Hutmacher et al 2000) 
 
5 CONCLUSION 
 
The combination of biologics and scaffold engineering represent a novel approach to promoting 
bony fusion in the setting of thoracic spine deformity correction. Application of computercontrolled 
extrusion- based additive manufacturing devices pave the way in customization of future spinal bone 
graft substitutes. 
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